BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32766147)

  • 41. Extragonadal germ cell tumors. A 14-year Toronto experience.
    Goss PE; Schwertfeger L; Blackstein ME; Iscoe NA; Ginsberg RJ; Simpson WJ; Jones DP; Shepherd FA
    Cancer; 1994 Apr; 73(7):1971-9. PubMed ID: 8137224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy analysis of three therapeutic modes on clinical stage Ia nonseminomatous germ cell testicular tumors].
    Dong P; Liu ZW; Li XD; Wu S; Li YH; Yao K; Qin ZK; Han H; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):256-60. PubMed ID: 23859330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center.
    Necchi A; Farè E; Vullo SL; Giannatempo P; Raggi D; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Verzoni E; Grassi P; Procopio G; Pizzocaro G; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2015 Aug; 13(4):385-391.e1. PubMed ID: 25726505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of surgical treatment for pimary germcell tumors of the mediastinum].
    Yano M; Fujii Y
    Nihon Geka Gakkai Zasshi; 2006 Nov; 107(6):278-83. PubMed ID: 17147287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012.
    Necchi A; Lo Vullo S; Bregni M; Rosti G; Mariani L; Raggi D; Giannatempo P; Secondino S; Schumacher K; Massard C; Kanfer E; Oechsle K; Laszlo D; Michieli M; Ifrah N; Mercier M; Crysandt M; Wuchter P; Nagler A; Wahlin A; Martino M; Badoglio M; Pedrazzoli P; Lanza F;
    Clin Genitourin Cancer; 2017 Feb; 15(1):163-167. PubMed ID: 27444987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary mediastinal germ cell tumors. Results of a French retrospective study.
    Lemarié E; Assouline PS; Diot P; Regnard JF; Levasseur P; Droz JP; Ruffié P
    Chest; 1992 Nov; 102(5):1477-83. PubMed ID: 1330448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
    Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW
    Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and Treatment of Testicular Cancer: A Clinician's Perspective.
    Bernard B; Sweeney CJ
    Surg Pathol Clin; 2015 Dec; 8(4):717-23. PubMed ID: 26612223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.
    Ruf CG; Isbarn H; Wagner W; Fisch M; Matthies C; Dieckmann KP
    Urol Oncol; 2014 Jan; 32(1):33.e1-6. PubMed ID: 23395239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 52. Primary malignant mediastinal germ-cell tumors and the contribution of radiotherapy: a southeastern multi-institutional study.
    Kersh CR; Eisert DR; Constable WC; Hahn SS; Jenrette JM; Fitzgerald RH; Grayson J
    Am J Clin Oncol; 1987 Aug; 10(4):302-6. PubMed ID: 3039830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy.
    Kim SH; Park WS; Kim SH; Joung JY; Seo HK; Lee KH; Chung J
    Cancer Res Treat; 2016 Jul; 48(3):1092-101. PubMed ID: 26875203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence of germ cell tumor after orchiectomy.
    van der Poel HG; Sedelaar JP; Debruyne FM; Witjes JA
    Urology; 2000 Sep; 56(3):467-73. PubMed ID: 10962317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
    Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
    [No Abstract]   [Full Text] [Related]  

  • 56. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
    Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
    J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience.
    Hallemeier CL; Choo R; Davis BJ; Leibovich BC; Costello BA; Pisansky TM
    Urol Oncol; 2014 Jan; 32(1):24.e1-6. PubMed ID: 23490907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors in children with extracranial malignant germ cell tumors: a monocentric pediatric Tunisian study.
    Fedhila F; Rhayem S; Hafsi H; Douira W; Doghri R; Khemiri M; Mrad K; Bellagha I; Zouari B; Barsaoui S
    Tunis Med; 2016 Apr; 94(4):309-314. PubMed ID: 27704516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
    Fizazi K; Delva R; Caty A; Chevreau C; Kerbrat P; Rolland F; Priou F; Geoffrois L; Rixe O; Beuzeboc P; Malhaire JP; Culine S; Aubelle MS; Laplanche A
    Eur Urol; 2014 Feb; 65(2):381-6. PubMed ID: 24094847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.